TM Owner Pfizer
Tygacil 50mg Injection
Global Shipping : Reliable Global Distribution Network
Express Delivery : Priority Shipping for Every Order
Secure Payments : Trusted Payment Protection System
Disclaimer
Secure Handling
24/7 Worldwide Support
Global Access
Worldwide Access to Health
Cold-Chain Expert
Excellence in Cold-Chain
Trusted Supply
Certified Medical Supply
Indications & Clinical Uses
- Tygacil (tigecycline) 50 mg is a broad-spectrum tetracycline antibiotic used to treat complicated skin and skin structure infections (cSSSI), complicated intra-abdominal infections (cIAI), and community-acquired bacterial pneumonia (CABP) caused by susceptible bacteria.
- It is administered by intravenous infusion in hospital or clinical settings.
- Tigecycline has activity against many Gram-positive and Gram-negative bacteria, anaerobes, and even some resistant organisms.
- It is particularly useful for infections caused by methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE).
- Tygacil is reserved for serious infections when other antibiotics are ineffective or contraindicated due to the risk of black box warning complications.
Side Effects
- Nausea and vomiting are very common, occurring in more than 25% of patients.
- Photosensitivity (severe sunburn-like reaction) can occur with sun exposure.
- Diarrhea, abdominal pain, and oral candidiasis (thrush) may develop during or after treatment.
- Headache and dizziness occur in some patients.
- A black box warning exists for increased mortality risk in critically ill patients compared to comparator antibiotics; tigecycline should be reserved for serious infections when alternative treatments are inadequate.
- Other serious adverse reactions include severe allergic reactions (anaphylaxis), hepatic impairment, pancreatitis, photosensitivity reactions, and severe skin reactions.
- Clostridium difficile-associated diarrhea (CDAD) can occur.
Precautions & Warnings
- Avoid direct sun exposure and use high-SPF sunscreen due to significant photosensitivity risk.
- The black box warning for increased mortality must be discussed with patients; use Tygacil only when benefits clearly outweigh risks and other antibiotics are inadequate.
- Tetracyclines can discolor developing teeth in fetuses and young children; avoid in pregnant women (especially third trimester) and children under 8 years unless no alternatives exist.
- Breastfeeding women should use alternatives as tetracyclines pass into milk.
- Monitor liver function in patients with hepatic impairment.
- Use caution in patients with renal impairment; dosage adjustment may be needed.
- Photosensitivity reactions may be severe and prolonged.
- Patients with inflammatory bowel disease have increased CDAD risk.
Avoid Interactions
- Warfarin and other anticoagulants: tigecycline may potentiate warfarin effect, increasing bleeding risk; monitor INR closely and adjust warfarin dose as needed.
- Oral contraceptives: tetracyclines may reduce contraceptive efficacy, increasing pregnancy risk; use backup contraception.
- Live vaccines should be avoided during antibiotic therapy.
- Dairy products, antacids, and iron supplements can reduce tigecycline absorption if taken within 2 hours; separate administration times.
- Photosensitizing medications (such as certain NSAIDs, thiazides) increase photosensitivity risk when combined.
- Retinoids increase intracranial pressure risk with tetracyclines.
- Do not mix tigecycline in solutions containing other medications.
- Inform your healthcare provider of all supplements and medications.
References
Frequently Asked Questions
Tygacil (tigecycline) is a broad-spectrum antibiotic used in hospitals for serious bacterial infections when other antibiotics have failed. It treats complicated skin infections, abdominal infections, and pneumonia caused by resistant bacteria including MRSA. Tygacil is given only by intravenous infusion because of a black box warning about increased mortality in certain patient populations.
Tygacil 50 mg is given only as an intravenous infusion in a hospital or clinical setting. The initial dose is 100 mg followed by 50 mg every 12 hours. Infusions run over 30-60 minutes. This medication is never self-administered at home because it requires medical supervision due to serious safety concerns.
Tygacil carries a black box warning: increased death rates have been observed compared to other antibiotics, especially in critically ill patients. Common side effects include severe nausea, vomiting, and severe sun sensitivity. Serious reactions include allergic reactions, liver damage, and bowel inflammation. Use Tygacil only when other antibiotics are insufficient.
Avoid sun exposure completely or use SPF 50+ sunscreen and protective clothing, as tetracyclines cause severe photosensitivity. Oral contraceptives may be less effective; use backup contraception. Warfarin effects may increase, raising bleeding risk. Antacids and dairy reduce absorption if given together. Tell your doctor about all medications.
Tygacil has a black box warning showing increased death risk compared to other antibiotics in some patient populations. Because of this serious safety concern, hospitals reserve it only for resistant infections where benefits clearly outweigh risks and no better alternatives exist. Your doctor will discuss why Tygacil is necessary for your specific infection.
Pregnant women should avoid Tygacil as it can permanently discolor developing teeth and cross into the placenta. Children under 8 years of age should not receive it for the same tooth-staining reason. Patients with severe liver disease need careful monitoring. Those with severe photosensitivity history or those unable to avoid sun should discuss alternatives with their doctor.
Trusted & Reliable – Your Partner in Global Distribution.
We provide comprehensive lines of pharmaceutical products to support all your healthcare distribution needs.
